Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression

Endocrinology

Volumn 155, Issue 2, 2014, Pages 558-567

  Liu, Guan Ying ^a   Liang, Qiu Hua ^a   Cui, Rong Rong ^a   Liu, Yuan ^a   Wu, Shan Shan ^a   Shan, Peng Fei ^b   Yuan, Ling Qing ^a   Liao, Er Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 4; CALCIUM; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTERY CALCIFICATION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CALCINOSIS; CALCIUM; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; LEPTIN; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; RANK LIGAND; RECEPTORS, LEPTIN;

EID: 84893204694     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1298     Document Type: Article

References (44)

1. EVOLVE Trial Investigators, Chertow GM, Block GA, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367: 2482-2494.
2. Fadini GP, Albiero M, Menegazzo L, et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circulation Res. 2011;108: 1112-1121.
3. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004;24: 1161-1170.
4. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006;26: 1423-1430.
5. Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol. 2012;8: 529-543.
6. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res. 2005;97: 105-114.
7. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21: 1998-2003.
8. Kaden JJ, Bickelhaupt S, Grobholz R, et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis. 2004;13: 560-566.
9. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003;23: 489-494.
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372: 425-432.
11. Folch J, Pedrós I, Patraca I, et al. Neuroprotective and anti-ageing role of leptin. J Mol Endocrinol. 2012;49:R149-R156.
12. Seufert J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes. 2004;53(suppl 1):S152-S158.
13. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res. 2001;88: 954-960.
14. Rodríguez A, Frühbeck G, Gómez-Ambrosi J, et al. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats. J Hypertens. 2006;24: 1589-1597.
15. Beltowski J. Leptin and atherosclerosis. Atherosclerosis. 2006;189: 47-60.
16. Correia ML, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens. 2004;13: 215-223.
17. Werner N, Nickenig G. From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vasc Biol. 2004;24: 7-9.
18. Zeadin MG, Butcher MK, Shaughnessy SG, Werstuck GH. Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β. Biochem Biophys Res Commun. 2012;425: 924-930.
19. Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. Effect of leptin on vascular calcification in apolipoprotein Edeficient mice. Arterioscler Thromb Vasc Biol. 2009;29: 2069-2075.
20. Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res. 2009; 24: 1461-1468.
21. Liang QH, Jiang Y, Zhu X, et al. Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway. PLoS One. 2012;7:e33126.
22. Luo XH, Guo LJ, Yuan LQ, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via theMAPKsignaling pathway. Exp Cell Res. 2005;309: 99-109.
23. Liao XB, Peng YQ, Zhou XM, et al. Taurine restores Axl/Gas6 expression in vascular smooth muscle cell calcification model. Amino Acids. 2010;39: 375-383.
24. Liao XB, Zhou XM, Li JM, et al. Taurine inhibits osteoblastic differentiation of vascular smooth muscle cells via the ERK pathway. Amino Acids. 2008;34: 525-530.
25. Shan PF, Lu Y, Cui RR, Jiang Y, Yuan LQ, Liao EY. Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells. PLoS One. 2011;6:e17938.
26. Panizo S, Cardus A, Encinas M, et al. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res. 2009;104: 1041-1048.
27. Yuan LQ, Zhu JH, Wang HW, et al. RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells. PLoS One. 2011;6:e29037.
28. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89: 2583-2589.
29. El Khoudary SR, Wildman RP, Matthews K, et al. Effect modification of obesity on associations between endogenous steroid sex hormones and arterial calcification in women at midlife. Menopause. 2011;18: 906-914.
30. Sabour S, Grobbee DE, Prokop M, van der Schouw YT, Bots ML. Change in abdominal obesity and risk of coronary calcification. J Epidemiol Community Health. 2011;65: 287-288.
31. Lee CD, Jacobs DR Jr, Schreiner PJ, Iribarren C, Hankinson A. Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2007;86: 48-54.
32. Atamer A, Alisir Ecder S, Akkus Z, et al. Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res. 2008;36: 522-528.
33. Reilly MP, Iqbal N, Schutta M, et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab. 2004;89: 3872-3878.
34. Grethen E, Hill KM, Jones R, et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab. 2012;97: 1655-1662.
35. Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93: 2106-2113.
36. Xie H, Xie PL, Wu XP, et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res. 2011;92: 296-306.
37. Huang F, Xiong X, Wang H, You S, Zeng H. Leptin-induced vascular smooth muscle cell proliferation via regulating cell cycle, activating ERK1/2 and NF-kappaB. Acta Biochim Biophys Sin (Shanghai). 2010;42: 325-331.
38. Shan J, Nguyen TB, Totary-Jain H, Dansky H, Marx SO, Marks AR. Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proc Natl Acad Sci USA. 2008;105: 19006-19011.
39. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995; 9: 726-735.
40. Marte BM, Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci. 1997;22: 355-358.
41. Kozma SC, Thomas G. Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays. 2002;24: 65-71.
42. WangSJ, Li XF, Jiang LS, Dai LY. Leptin regulates estrogen receptor gene expression in ATDC5 cells through the extracellular signal regulated kinase signaling pathway. J Cell Biochem. 2012;113: 1323-1332.
43. Chavez RJ, Haney RM, Cuadra RH, et al. Upregulation of thrombospondin- 1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathways. Am J Physiol Cell Physiol. 2012;303:C179-C191.
44. Wang D, Chen J, Chen H, et al. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway. J Biosci. 2012;37: 91-101.